Zhong Huahua, Zheng Yiming, Zhao Zhe, Lin Pengfei, Xi Jianying, Zhu Wenhua, Lin Jie, Lu Jun, Yu Meng, Zhang Wei, Lv He, Yan Chuanzhu, Hu Jing, Wang Zhaoxia, Lu Jiahong, Zhao Chongbo, Yuan Yun, Luo Sushan
Department of Neurology, Huashan Hospital Fudan University, Shanghai, China.
Department of Neurology, Peking University First Hospital, Beijing, China.
J Med Genet. 2021 Nov;58(11):729-736. doi: 10.1136/jmedgenet-2020-107159. Epub 2020 Sep 29.
Limb-girdle muscular dystrophy type R1 (LGMDR1) can be caused by recessive CAPN3 mutations accounting for the majority of LGMD. To date, no systemic evaluation has been performed to analyse the detrimental and normal mutations on CAPN3 and its hotspots.
CAPN3 variants (n=112) from a total of 124 patients with LGMDR1 recruited in four centres in China were retrospectively analysed. Then external CAPN3 variants (n=2031) from online databases were integrated with our Chinese cohort data to achieve a worldwide perspective on CAPN3 mutations. According to their related phenotypes (LGMDR1 or normal), we analysed consequence, distribution, ethnicity and severity scores of CAPN3 mutations.
Two hotspot mutations were identified including c.2120A>G in Chinese population and c.550del in Europe. According to the integrated dataset, 521 mutations were classified as LGMDR1-related and converged on exons 1, 10, 5, 22 and 13 of CAPN3. The remaining 1585 variants were classified as normal-population related. The deleterious ratio of LGMDR1-relevant variants to total variants in each population was 0.26 on average with a maximum of 0.35 in Finns and a minimum of 0.21 in South Asians. Severity evaluation showed that Chinese LGMDR1-related variants exhibited a higher risk (Combined Annotation Dependent Depletion score +1.10) than that from database patients (p<0.001).
This study confirmed two hotspots and LGMDR1-related CAPN3 variants, highlighting the advantages in using a data-based comprehensive analysis to achieve a genetic landscape for patients with LGMDR1.
R1型肢带型肌营养不良症(LGMDR1)可由隐性钙蛋白酶3(CAPN3)突变引起,该突变占肢带型肌营养不良症的大部分。迄今为止,尚未进行系统评估来分析CAPN3上的有害突变和正常突变及其热点区域。
回顾性分析了在中国四个中心招募的124例LGMDR1患者的112个CAPN3变异体。然后将来自在线数据库的外部CAPN3变异体(2031个)与我们的中国队列数据整合,以全面了解全球范围内的CAPN3突变情况。根据它们相关的表型(LGMDR1或正常),我们分析了CAPN3突变的后果、分布、种族和严重程度评分。
鉴定出两个热点突变,包括中国人群中的c.2120A>G和欧洲人群中的c.550del。根据整合数据集,521个突变被分类为与LGMDR1相关,并集中在CAPN3的外显子1、10、5、22和13上。其余1585个变异体被分类为与正常人群相关。各人群中与LGMDR1相关的变异体占总变异体的有害比例平均为0.26,芬兰人最高为0.35,南亚人最低为0.21。严重程度评估显示,中国与LGMDR1相关的变异体比数据库中的患者表现出更高的风险(联合注释依赖损耗评分+1.10)(p<0.001)。
本研究证实了两个热点区域以及与LGMDR1相关的CAPN3变异体,突出了使用基于数据的综合分析来构建LGMDR1患者遗传图谱的优势。